APA

Efimova E. V., Al-Zoubi A. M., Martinez O., Kaithamana S., Lu S., Arima T. & Prabhakar B. S. (20040310). IG20, in contrast to DENN-SV, (MADD splice variants) suppresses tumor cell survival, and enhances their susceptibility to apoptosis and cancer drugs. : Oncogene.

Chicago

Efimova Elena V, Al-Zoubi Adeeb M, Martinez Osvaldo, Kaithamana Shashi, Lu Shenfeng, Arima Takayasu and Prabhakar Bellur S. 20040310. IG20, in contrast to DENN-SV, (MADD splice variants) suppresses tumor cell survival, and enhances their susceptibility to apoptosis and cancer drugs. : Oncogene.

Harvard

Efimova E. V., Al-Zoubi A. M., Martinez O., Kaithamana S., Lu S., Arima T. and Prabhakar B. S. (20040310). IG20, in contrast to DENN-SV, (MADD splice variants) suppresses tumor cell survival, and enhances their susceptibility to apoptosis and cancer drugs. : Oncogene.

MLA

Efimova Elena V, Al-Zoubi Adeeb M, Martinez Osvaldo, Kaithamana Shashi, Lu Shenfeng, Arima Takayasu and Prabhakar Bellur S. IG20, in contrast to DENN-SV, (MADD splice variants) suppresses tumor cell survival, and enhances their susceptibility to apoptosis and cancer drugs. : Oncogene. 20040310.